ASF Research Grants
ASF Research Grants from the Angelman Syndrome Foundation fund innovative research to advance understanding and treatment of Angelman syndrome, with a focus on translational and therapeutic science.
Funder: Angelman Syndrome Foundation
Due Dates: August 15, 2026 | September 1, 2026
Funding Amounts: Up to $100,000 per year for 1–2 years; indirect costs capped at 10% (included in total).
Summary: Supports innovative, translational research to advance understanding and treatment of Angelman syndrome worldwide.
Key Information: Proposals must align with ASF’s strategic research priorities and be submitted as a single PDF.
Description
The Angelman Syndrome Foundation (ASF) Research Grants program funds pioneering scientific research that advances the understanding, diagnosis, and treatment of Angelman syndrome (AS). The program welcomes proposals from researchers and clinicians globally, with a focus on studies that are innovative, collaborative, and have clear translational potential. ASF’s funding priorities are guided by its Research Roadmap, emphasizing UBE3A regulation, development of novel therapies (including gene and small molecule therapies), improvements in clinical care, and the identification of therapeutic endpoints and biomarkers. The ultimate goal is to accelerate discoveries that can directly benefit individuals living with Angelman syndrome.
